West Pharmaceutical Services (WST)
EBITDA Margin
26.17%
TTM · Period ending:

WST EBITDA Margin
Latest reported26.17%period ending
Latest reported26.17%period ending
WST TTM EBITDA Margin (19.87% → 26.17%)
TTM ebitda margin
High-resolution chart · PNG
WST ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 10.6071% | |
| 8.2763% | |
| 8.3469% | |
| 10.0159% | |
| 11.2885% | |
| 12.9269% | |
| 14.1548% | |
| 21.0245% | |
| 21.2925% | |
| 20.8851% | |
| 14.3874% | |
| 8.0783% | |
| 7.4593% | |
| 7.5169% | |
| 13.6354% | |
| 13.1993% | |
| 12.7669% | |
| 12.141% | |
| 11.6173% | |
| 10.757% | |
| 10.2355% | |
| 10.4727% | |
| 11.6977% | |
| 11.9189% | |
| 12.7719% | |
| 13.1297% | |
| 12.9006% | |
| 13.3501% | |
| 13.3314% | |
| 12.9837% | |
| 11.7866% | |
| 10.8917% | |
| 10.5906% | |
| 10.836% | |
| 11.6499% | |
| 1.7771% | |
| 1.6652% | |
| 0.3995% | |
| -0.364% | |
| 7.5023% | |
| 7.0111% | |
| 6.4209% | |
| 6.6522% | |
| -53.3023% | |
| -34.3492% | |
| -11.0435% | |
| 11.6942% | |
| 15.3088% | |
| 15.1974% | |
| 13.7793% | |
| 10.5482% | |
| 20.0143% | |
| 16.4235% | |
| 14.3076% | |
| 11.8042% | |
| 17.386% | |
| 17.386% | |
| 16.1686% | |
| 13.073% | |
| 25.0225% | |
| 19.8653% |